Works matching DE "ENFUVIRTIDE (Drug)"

Results: 36

Action of enfuvirtide on the pregnancy of albino rats (Rattus norvegicus albinus, Rodentia, Mammalia): biological assay and functional and histological analyses of exposed maternal-fetal organs.

Published in:

Einstein (16794508), 2023, v. 21, p. 1, doi. 10.31744/einstein_journal/2023AO0230

By:

de Moraes, Renata Delphim;
Araujo Júnior, Edward;
Castelo Filho, Adauto;
Borges Peixoto, Alberto;
Mahmed Amed, Abês

Publication type:

Article

HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay.

Published in:

PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0206365

By:

Yang, Edward;
Gardner, Matthew R.;
Zhou, Amber S.;
Farzan, Michael;
Arvin, Ann M.;
Oliver, Stefan L.

Publication type:

Article

Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production.

Published in:

Microbial Cell Factories, 2016, v. 15, p. 1, doi. 10.1186/s12934-016-0502-y

By:

Ongey, Elvis Legala;
Neubauer, Peter

Publication type:

Article

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 3, p. 690

By:

Charpentier, Charlotte;
Joly, Véronique;
Larrouy, Lucile;
Fagard, Catherine;
Visseaux, Benoit;
de Verdière, Nathalie Colin;
Raffi, François;
Yeni, Patrick;
Descamps, Diane

Publication type:

Article

Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2099

By:

Gallien, Sébastien;
Braun, Joséphine;
Delaugerre, Constance;
Charreau, Isabelle;
Reynes, Jacques;
Jeanblanc, François;
Verdon, Renaud;
de Truchis, Pierre;
May, Thierry;
Madelaine-Chambrin, Isabelle;
Aboulker, Jean-Pierre;
Molina, Jean-Michel

Publication type:

Article

Genetic and Structural Analysis of HIV-1 Rev Responsive Element Related to V38A and T18A Enfuvirtide Resistance Mutations.

Published in:

Intervirology, 2012, v. 55, n. 5, p. 385, doi. 10.1159/000334696

By:

Dimonte, Salvatore;
Mercurio, Fabio;
Svicher, Valentina;
Perno, Carlo-Federico;
Ceccherini-Silberstein, Francesca

Publication type:

Article

Pharmacokinetic profile in late pregnancy and cord blood concentration of tipranavir and enfuvirtide.

Published in:

International Journal of STD & AIDS, 2011, v. 22, n. 5, p. 294, doi. 10.1258/ijsa.2009.009166

By:

Weizsaecker, K.;
Kurowski, M.;
Hoffmeister, B.;
Schürmann, D.;
Feiterna-Sperling, C.

Publication type:

Article

Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action.

Published in:

PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060302

By:

Hollmann, Axel;
Matos, Pedro M.;
Augusto, Marcelo T.;
Castanho, Miguel A. R. B.;
Santos, Nuno C.

Publication type:

Article

A Compensatory Mutation Provides Resistance to Disparate HIV Fusion Inhibitor Peptides and Enhances Membrane Fusion.

Published in:

PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055478

By:

Wood, Matthew P.;
Cole, Amy L.;
Ruchala, Piotr;
Waring, Alan J.;
Rohan, Lisa C.;
Marx, Preston;
Tarwater, Patrick M.;
Gupta, Phalguni;
Cole, Alexander M.

Publication type:

Article

A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro.

Published in:

PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041235

By:

Chien-Hsing Chang;
Hinkula, Jorma;
Meiyu Loo;
Falkeborn, Tina;
Rongxiu Li;
Cardillo, Thomas M.;
Rossi, Edmund A.;
Goldenberg, David M.;
Wahren, Britta

Publication type:

Article

Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates.

Published in:

PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0021535

By:

Baatz, Franky;
Nijhuis, Monique;
Lemaire, Morgane;
Riedijk, Martiene;
Wensing, Annemarie M. J.;
Servais, Jean-Yves;
Van Ham, Petra M.;
Hoepelman, Andy I. M.;
Koopmans, Peter P.;
Sprenger, Herman G.;
Devaux, Carole;
Schmit, Jean-Claude;
Bercoff, Danielle Perez

Publication type:

Article

Susceptibility of HIV-1 Subtypes B9, CRF07BC and CRF01AE that Are Predominantly Circulating in China to HIV-1 Entry Inhibitors.

Published in:

PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017605

By:

Xiaoling Yu;
Lin Yuan;
Yang Huang;
Weisi Xu;
Zhiming Fang;
Shuwen Liu;
Yiming Shao;
Shibo Jiang;
Liying Ma

Publication type:

Article

Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1.

Published in:

FASEB Journal, 2012, v. 26, n. 11, p. 4628, doi. 10.1096/fj.12-215111

By:

Ashkenazi, Avraham;
Viard, Mathias;
Unger, Linor;
Blumenthal, Robert;
Shai, Yechiel

Publication type:

Article

Section: bioprocessing and biological engineering gene fragment polymerization for increased yield of recombinant HIV fusion inhibitor enfuvirtide.

Published in:

Biotechnology Letters, 2014, v. 36, n. 9, p. 1761, doi. 10.1007/s10529-014-1556-8

By:

Gudipudi, Anil;
Bajji, Chitra;
Kosana, Ravikanth;
Panati, Kalpana;
Lomada, Dakshayani;
Arva Tatireddigari, Venkat;
Narala, Venkata

Publication type:

Article

Erratum to: Gene fragment polymerization for increased yield of recombinant HIV fusion inhibitor Enfuvirtide.

Published in:

2014

By:

Gudipudi, Anil;
Bajji, Chitra;
Kosana, Ravikanth;
Panati, Kalpana;
Lomada, Dakshayani;
Arva Tatireddigari, Venkat;
Narala, Venkata

Publication type:

Erratum

Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy.

Published in:

Scientific Reports, 2015, p. 13028, doi. 10.1038/srep13028

By:

Zhu, Xiaojie;
Zhu, Yun;
Ye, Sheng;
Wang, Qian;
Xu, Wei;
Su, Shan;
Sun, Zhiwu;
Yu, Fei;
Liu, Qi;
Wang, Chao;
Zhang, Tianhong;
Zhang, Zhenqing;
Zhang, Xiaoyan;
Xu, Jianqing;
Du, Lanying;
Liu, Keliang;
Lu, Lu;
Zhang, Rongguang;
Jiang, Shibo

Publication type:

Article

Short-course intensification with enfuvirtide in virologic failure: impact on intracellular HIV reservoir and on viral tropism (INNOVE study).

Published in:

Journal of the International AIDS Society, 2010, v. 13, p. P40, doi. 10.1186/1758-2652-13-S4-P40

By:

Ghosn, J;
Delaugerre, C;
Pinta, A;
Pierre, N;
Etienne, D;
Raffi, F;
Morand-Joubert, L

Publication type:

Article

Enfuvirtide in therapy at patients with HIV-infection and tuberculosis.

Published in:

Journal of the International AIDS Society, 2010, v. 13, p. P197, doi. 10.1186/1758-2652-13-S4-P197

By:

Kravchenko, AV;
Kuznetsova, AV;
Kozyrev, OA;
Lukyanova, VA;
Kanestri, VG

Publication type:

Article

Short-course intensification with enfuvirtide in virologic failure: impact on intracellular HIV reservoir and on viral tropism (INNOVE study).

Published in:

2010

By:

Ghosn, J.;
Delaugerre, C.;
Pinta, A.;
Pierre, N.;
Etienne, D.;
Raffi, F.;
Morand-Joubert, L.

Publication type:

Abstract

The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance.

Published in:

PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0171567

By:

Cao, Ping;
Dou, Guifang;
Cheng, Yuanguo;
Che, Jinjing

Publication type:

Article

Relapse of Intravenous Drug Use Triggered by Enfuvirtide, a Parenteral Antiretroviral Medication.

Published in:

AIDS Patient Care & STDs, 2012, v. 26, n. 2, p. 71, doi. 10.1089/apc.2011.0343

By:

Avelino-Silva, Vivian Iida;
Li, Ho Yeh;
Novaes, Christina Terra Gallafrio

Publication type:

Article

Antiviral Briefs.

Published in:: AIDS Patient Care & STDs, 2010, v. 24, n. 12, p. 805, doi. 10.1089/apc.2010.9890
Publication type:: Article

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.

Published in:

AIDS Research & Therapy, 2016, p. 1, doi. 10.1186/S12981-016-0101-3

By:

de Castro, Nathalie;
Braun, Joséphine;
Charreau, Isabelle;
Lafeuillade, Alain;
Viard, Jean-Paul;
Allavena, Clotilde;
Aboulker, Jean-Pierre;
Molina, Jean-Michel

Publication type:

Article

A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.

Published in:

Molecules, 2019, v. 24, n. 6, p. 1134, doi. 10.3390/molecules24061134

By:

Su, Shan;
Rasquinha, Giselle;
Du, Lanying;
Wang, Qian;
Xu, Wei;
Li, Weihua;
Lu, Lu;
Jiang, Shibo

Publication type:

Article

The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.

Published in:

HIV Medicine, 2011, v. 12, n. 2, p. 65, doi. 10.1111/j.1468-1293.2010.00848.x

By:

Carsenti-Dellamonica, H.;
Saïdi, H.;
Ticchioni, M.;
Guillouet de Salvador, F.;
Dufayard Cottalorda, J.;
Garraffo, R.;
Dellamonica, P.;
Durant, J.;
Gougeon, M.-L.

Publication type:

Article

The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy.

Published in:

HIV Medicine, 2011, v. 12, n. 1, p. 31, doi. 10.1111/j.1468-1293.2010.00845.x

By:

Cooper, D. A.;
Cordery, D. V.;
Reiss, P.;
Henry, K.;
Nelson, M.;
O'Hearn, M.;
Reynes, J.;
Arastéh, K.;
Chung, J.;
Rowell, L.;
Guimaraes, D.;
Bertasso, A

Publication type:

Article

Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide.

Published in:

Viruses (1999-4915), 2019, v. 11, n. 5, p. 439, doi. 10.3390/v11050439

By:

Dingens, Adam S.;
Arenz, Dana;
Overbaugh, Julie;
Bloom, Jesse D.

Publication type:

Article

Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.

Published in:

PLoS Pathogens, 2016, v. 12, n. 11, p. 1, doi. 10.1371/journal.ppat.1005983

By:

Leslie, George J.;
Haggarty, Beth S.;
Jordon, Andrea P. O.;
Romano, Josephine;
Kumar, Kritika E.;
Hoxie, James A.;
Wang, Jianbin;
Hua, Kevin L.;
Duong, Jennifer;
DeClercq, Joshua J.;
Gregory, Philip D.;
Holmes, Michael C.;
Richardson, Max W.;
Riley, James L.;
Secreto, Anthony J.;
June, Carl H.;
Root, Michael J.

Publication type:

Article

Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.

Published in:

Infection, 2012, v. 40, n. 1, p. 69, doi. 10.1007/s15010-011-0223-4

By:

Bonora, S.;
Calcagno, A.;
Cometto, C.;
Fontana, S.;
Aguilar, D.;
D'Avolio, A.;
Gonzalez de Requena, D.;
Maiello, A.;
Dal Conte, I.;
Lucchini, A.;
Di Perri, G.

Publication type:

Article

Modelling two different therapy strategies for drug T-20 on HIV-1 patients.

Published in:

Applied Mathematics & Mechanics, 2011, v. 32, n. 4, p. 419, doi. 10.1007/s10483-011-1427-8

By:

Song, Bao-jun;
Lou, Jie;
Wen, Qing-zhi

Publication type:

Article

Nodular amyloidosis at the sites of insulin injections.

Published in:

Journal of Cutaneous Pathology, 2015, v. 42, n. 7, p. 496, doi. 10.1111/cup.12501

By:

Bernárdez, Claudia;
Schärer, Leo;
Molina‐Ruiz, Ana María;
Requena, Luis

Publication type:

Article

A Novel Form of Amyloid Deposited at the Site of Enfuvirtide Injection.

Published in:

Journal of Cutaneous Pathology, 2012, v. 39, n. 2, p. 220, doi. 10.1111/j.1600-0560.2012.01865_2.x

By:

Naujokas, Agne;
Vidal, Claudia I.;
Mercer, Steven E.;
Harp, Joanna;
Kurtin, Paul J.;
Fox, Lindy P.;
Thompson, Michele M.

Publication type:

Article

Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naïve Korean patients.

Published in:

Archives of Virology, 2016, v. 161, n. 6, p. 1547, doi. 10.1007/s00705-016-2807-x

By:

Shin, YoungHyun;
Yoon, Cheol-Hee;
Yang, Hyo-Jin;
Lim, Hoyong;
Choi, Byeong-Sun;
Kim, Sung;
Kang, Chun

Publication type:

Article

Mathematical Modelling of Enfuvirtide and Protease Inhibitors as Combination Therapy for HIV.

Published in:

International Journal of Nonlinear Sciences & Numerical Simulation, 2016, v. 17, n. 6, p. 259, doi. 10.1515/ijnsns-2015-0051

By:

Chowdhury, Sonia;
Roy, Priti Kumar;
Smith?, Robert J.

Publication type:

Article

Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy.

Published in:

Journal of Infectious Diseases, 2013, v. 208, n. 6, p. 892, doi. 10.1093/infdis/jit280

By:

Silva, Erika F.;
Charreau, Isabelle;
Gourmel, Bernard;
Mourah, Samia;
Kalidi, Issa;
Guillon, Brigitte;
De Castro, Nathalie;
Caron, François;
Braun, Josephine;
Molina, Jean-Michel

Publication type:

Article

Fuzeon-Induced Collagenophagic Granuloma: A Peculiar Granulomatous Injection Site Reaction to Fuzeon- A Case Report and Review of Literature.

Published in:

2010

By:

Sidhu, Harleen K.;
Chaffee, Barbara H.;
Tvetenstrand, Christian D.;
Sidhu, Jagmohan S.

Publication type:

Case Study